According to Emergen Research, the global in-situ hybridization market size was USD 905.3 million in 2020 and is expected to reach USD 1,556.6 million in 2028 and register a revenue CAGR of 7.1% during the forecast period, 2021-2028.
Emergen Research has published its latest report titled “In-Situ Hybridization Market, By Product Type (Kits & Reagents, Probes, Instruments, Software, and Others), By Technology (Fluorescence In-Situ Hybridization, Chromogenic In-Situ Hybridization), By Application (Cancer Diagnostics, Infectious Diseases, Immunology, Neuroscience, Cytology, and Others), By End-use (Hospitals, Diagnostics Laboratories, Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Others), and By Region, Forecast to 2028”
According to Emergen Research, the global in-situ hybridization market size was USD 905.3 million in 2020 and is expected to reach USD 1,556.6 million in 2028 and register a revenue CAGR of 7.1% during the forecast period, 2021-2028.
Market Dynamics:
The global in-situ hybridization market revenue growth is majorly driven by factors such as rise in geriatric population across the globe, increasing burden of chronic diseases such as cancer, infectious diseases, and genetic disorders, growing need for advanced and cutting-edge solutions for early detection and treatment of infected tissue and cells, and increasing government investments in pharmaceutical and biotechnological research & development activities for newer and more effective diagnostic and therapeutic solutions for cancer.
Other major factors expected to drive the global in-situ hybridization market revenue growth during the forecast period are rising cases of severe infectious diseases such as the novel coronavirus and increasing adoption of in-situ hybridization technology in hospitals and diagnostic centers. However, the global market revenue growth is hampered by factors such as rising costs associated with in-situ hybridization-based treatments.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/584
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Kits & Reagents Segment Accounted for Largest Revenue Share in 2020:
Based on product type, the global in-situ hybridization market is segmented into kits & reagents, probes, instruments, software, and others. The kits & reagents segment dominated other segments in terms of revenue share in the global market in 2020. Key factors contributing to this segment’s revenue growth are rising prevalence of cancer and chronic infectious disorders across the world, and increasing use of technologically advanced kits & reagents in clinical procedures such as hybridization, pre-hybridization, and post-hybridization.
Fluorescence In-Situ Hybridization Technology Segment to Expand at Fastest Revenue CAGR:
Based on technology, the global in-situ hybridization market is segmented into fluorescence in-situ hybridization and chromogenic in-situ hybridization. The fluorescence in-situ hybridization segment is expected to dominate other segments in terms of fastest revenue CAGR in the global market over the forecast period due to some favorable factors. Growing use of the fluorescence in-situ hybridization technology in defected chromosome identification, diagnosis of unusual genetic conditions, and drug development tracking is one of the major factors driving this segment’s revenue growth.
North America Accounted for Largest Revenue Share in 2020:
The North America in-situ hybridization market dominated other regional markets in terms of largest revenue share in the global market in 2020. Key factors driving the North America market revenue growth are increasing burden of severe chronic diseases such as cancer and infectious disorders, increasing adoption of advanced in-situ hybridization techniques in clinical laboratories and research institutions, and rise in government investments in the pharmaceutical and biotechnology sectors for research & development activities. Presence of avant-garde healthcare infrastructure and key market players in the region, including Agilent Technologies, Abbott Laboratories, and Thermo Fisher Scientific, is another factor boosting market revenue growth in North America.
Buy your Exclusive copy@ https://www.emergenresearch.com/select-license/584
Major Companies in the Market Include:
- Thermo Fisher Scientific
- Biocare Medical
- Agilent Technologies
- Abbott Laboratories
- Abnova Corporation
- Hoffmann-La Roche Ltd.
- Merck KGAa
- Danaher Corporation
- Bio SB
- BioGenex Laboratories
For the purpose of this report, Emergen Research has segmented the global in-situ hybridization market on the basis of product type, technology, application, end-use, and region:
Product Type Outlook (Revenue, USD Million; 2018–2028)
- Kits & Reagents
- Probes
- Instruments
- Software
- Others
Technology Outlook (Revenue, USD Million; 2018–2028)
- Fluorescence In-Situ Hybridization (FISH)
- Chromogenic In-Situ Hybridization (CISH)
Application Outlook (Revenue, USD Million; 2018–2028)
- Cancer Diagnostics
- Infectious Disease
- Immunology
- Neuroscience
- Cytology
- Others
End-use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals
- Diagnostics Laboratories
- Pharmaceutical and Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Others
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/in-situ-hybridization-market
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Take a Look at our Related Reports:
Organs-on-Chips Market By Type (Liver-on-Chip, Multiple Organs-on-Chips, Kidney-on-Chip, Heart-on-Chip, Lung-on-Chip, Intestine-on-Chip), By Application (Drug Discovery, Physiological Model Development, Toxicology Research), By End-Use (Pharmaceutical Firms, Research Institutes, Personal Care Industry), and By Region Forecast to 2028
RNA Transcriptomics Market By Product (Reagents, Instruments, Software, Service), By Technology (Microarrays, Polymerase Chain Reaction, RNA Sequencing, RNA Interference), By Application (Clinical Diagnostics, Toxicogenomics, Drug Discovery, Comparative Transcriptomics), By End-Use (Hospitals, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations). and By Region
Slide Stainers Market By Product (Reagents, Consumables & Accessories, Equipment), By Technology (Hematoxylin and Eosin, Immunohistochemistry, In Situ Hybridization, Cytology, Microbiology, Hematology, Special Stains), By End-Use (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Other), and By Region Forecast to 2028
High-performance Liquid Chromatography (HPLC) Market By Product (Instruments, Accessories, Consumables), By Application (Clinical Research, Forensic, Diagnostics, Other), By End-Use (Pharma and Bio-pharmaceutical Companies, Contract Research Organizations, Academic Institutions and Others), and By Region Forecast to 2028
Flow Imaging Microscopy Market By Sample Type (Large Biomolecule, Small Biomolecules, Liquid & Viscous Samples, Microfibers and Nano fibers, Others), By Sample Dispersion (Wet Dispersion, Dry Dispersion), By End-Use (Biotechnology Companies, Pharmaceutical Companies, Water Testing Laboratories, Food & Beverage Companies, Research & Academia, Metal Manufacturing, Chemical & Petrochemical Industries), and By Region Forecast to 2028
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Full Press Release@ https://www.emergenresearch.com/press-release/global-in-situ-hybridization-market